Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › PRAX

SILVERARC CAPITAL MANAGEMENT, LLC position in PRAX

PRAXIS PRECISION MEDICINES I · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 19,753 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 0.73% of its reported portfolio and ranking #35 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed PRAX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)19.75K sh
Reported value held$5.75M
Portfolio Weight0.73%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's PRAX position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in PRAX in Q3 2023 at 4,117,920 shares (US$7.0M). The position peaked in Q4 2025 at 82,465 shares, worth US$24.3M. Across 13 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 19,753 shares valued at US$5.8M — a reduction of -45,926 shares quarter over quarter.. Notable position changes include a 129% increase in Q1 2025 (shares rose 11% over the following quarter), a 94% trim in Q2 2025 (shares rose 26% over the following quarter), a 412% increase in Q3 2025 (shares rose 456% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.12M $7.04M New
Q4 2023 283.84K $6.32M Reduce
Q1 2024 190.56K $11.63M Reduce
Q2 2024 67.30K $2.78M Reduce
Q3 2024 67.05K $3.86M Hold
Q4 2024 72.52K $5.58M Add
Q1 2025 166.07K $6.29M Add
Q2 2025 10.00K $420.50K Reduce
Q3 2025 51.21K $2.71M Add
Q4 2025 82.47K $24.31M Add
Q1 2026 71.55K $23.05M Reduce
Q2 2026 65.68K $21.99M Reduce
Q3 2026 19.75K $5.75M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRAX and 13F data

PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 69 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRAX

All PRAX fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held PRAX?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed PRAX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in PRAX?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 19.75K shares of PRAX (PRAXIS PRECISION MEDICINES I), valued at $5.75M, representing 0.73% of its reported portfolio and ranking #35.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling PRAX?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC reduced its position in PRAX. The position peaked in Q4 2025 at 82.47K shares.

Which other funds hold PRAX?

Other major institutional holders of PRAX include Jupiter Topco LLC, Janus Henderson Group, PERCEPTIVE ADVISORS LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.